Vivo Opportunity Cayman Fund, LP

Vivo Opportunity LLC (10% owner) bought 20,546 shares at $1.55 across 6 transactions (July 14-16); holdings now 75,019 shares (+37.7%).

Vivo Opportunity, LLC executed 6 separate purchases totaling 20,546 shares for $31,846.30 at $1.55 per share over a three-day window (July 14–16, 2026), increasing its holding by 37.7% from 54,473 to 75,019 shares. The current stock price of $1.59 is -51.5% from its 52-week high of $3.28, though it has appreciated +7.4% over the past 30 days and +123.9% over 90 days. InMed Pharmaceuticals reported quarterly revenue of $820,188.00 and a net loss of $-2,966,336.00, with the company unprofitable over its most recent full fiscal year. The insider's 5 prior trades at this ticker (all buys in late June–early July) remain too recent to measure outcomes; across all prior open-market activity at other tickers, the insider has averaged a +2.0% 30-day return on 20 buy transactions.

10% owner Vivo Opportunity buys 6,551 shares (6.6K) at $1.54–$1.55 over 3 days for $10,148.05

Vivo Opportunity, LLC (10% owner of InMed Pharmaceuticals) executed 6 separate purchases totaling 6,551 shares for $10,148.05 at blended average price $1.55 between June 30 and July 2, 2026, increasing holdings by 9.8% to 73,135 shares. The current price of $1.56 is nearly identical to the transaction prices, placing the stock 56.1% below its 52-week high of $3.55 and within the recent 90-day rebound of 130.1%. InMed remains unprofitable ($-3.0M net income in the latest full fiscal year) with minimal quarterly revenue ($820.2K), though annual revenue growth stands at 7.5%. Prior trades by Vivo Opportunity at this same ticker (5 buys on 2026-06-04 through 2026-06-08) are too recent to have measurable returns. The cross-ticker track record shows 18 prior buys averaging -2.6% 30-day return, providing limited predictive value for this specific transaction.

10% owner Vivo Opportunity bought 249,227 shares for $391,554.51 across 18 trades (May–June 2026), blended avg $1.57.

Vivo Opportunity, LLC, a 10% shareholder, executed 18 separate purchases totaling 249,227 shares for $391,554.51 between May 20 and June 8, 2026, at prices ranging from $1.52 to $1.69 with a blended average of $1.57. The transaction occurred amid significant stock volatility: the current price of $1.51 is -72.6% from the 52-week high of $5.50, while the stock has gained +143.2% over the past 30 days and +88.8% over 90 days. The company reported a net loss of $-3.0M on quarterly revenue of $820.2K and remains unprofitable on a full-year basis, with a market cap of $5.0M. The fractured purchase pattern (small add-ons paired with larger blocks on each date) and multi-week accumulation at depressed valuations relative to the 52-week range warrant attention as to whether this represents a significant capital commitment by an existing major shareholder or portfolio-level activity.